Reciprocal relationship between myeloid-derived suppressor cells and T cells

Journal of Immunology

Volumn 191, Issue 1, 2013, Pages 17-23

  Nagaraj, Srinivas ^a   Youn, Je In ^b   Gabrilovich, Dmitry I ^a,b,c  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^c WISTAR INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

CANCER PATIENT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL FUNCTION; CELL INTERACTION; DISEASE ASSOCIATION; EXPERIMENTAL ANIMAL; GENETICS; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOREGULATION; INFLAMMATION; LIVER INJURY; MICROENVIRONMENT; MOUSE; MYELOID DERIVED SUPPRESSOR CELL; NONHUMAN; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; REVIEW; SUPPRESSOR CELL; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH17 CELL; TH2 CELL; TUMOR IMMUNOLOGY;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CELL COMMUNICATION; HUMANS; INFLAMMATION; MICE; MONOCYTES; MYELOID CELLS; NEOPLASMS;

EID: 84879637291     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1300654     Document Type: Review

References (87)

1. Movahedi, K., M. Guilliams, J. Van den Bossche, R. Van den Bergh, C. Gysemans, A. Beschin, P. De Baetselier, and J. A. Van Ginderachter. 2008. Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity. Blood 111: 4233-4244.
2. Youn, J. I., S. Nagaraj, M. Collazo, and D. I. Gabrilovich. 2008. Subsets of myeloid-derived suppressor cells in tumor-bearing mice. J. Immunol. 181: 5791-5802.
3. Gabrilovich, D. I., S. Ostrand-Rosenberg, and V. Bronte. 2012. Coordinated regulation of myeloid cells by tumours. Nat. Rev. Immunol. 12: 253-268.
4. Youn, J.-I., M. Collazo, I. N. Shalova, S. K. Biswas, and D. I. Gabrilovich. 2012. Characterization of the nature of granulocytic myeloid-derived suppressor cells in tumor-bearing mice. J. Leukoc. Biol. 91: 167-181.
5. Youn, J. I., V. Kumar, M. Collazo, Y. Nefedova, T. Condamine, P. Cheng, A. Villagra, S. Antonia, J. C. McCaffrey, M. Fishman, et al. 2013. Epigenetic silencing of retinoblastoma gene regulates pathologic differentiation of myeloid cells in cancer. Nat. Immunol. 14: 211-220.
6. Corzo, C. A., T. Condamine, L. Lu, M. J. Cotter, J. I. Youn, P. Cheng, H. I. Cho, E. Celis, D. G. Quiceno, T. Padhya, et al. 2010. HIF-1a regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment. J. Exp. Med. 207: 2439-2453.
7. Solito, S., V. Bronte, and S. Mandruzzato. 2011. Antigen specificity of immune suppression by myeloid-derived suppressor cells. J. Leukoc. Biol. 90: 31-36.
8. Ostrand-Rosenberg, S., and P. Sinha. 2009. Myeloid-derived suppressor cells: linking inflammation and cancer. J. Immunol. 182: 4499-4506.
9. Raber, P., A. C. Ochoa, and P. C. Rodríguez. 2012. Metabolism of L-arginine by myeloid-derived suppressor cells in cancer: mechanisms of T cell suppression and therapeutic perspectives. Immunol. Invest. 41: 614-634.
10. Monu, N. R., and A. B. Frey. 2012. Myeloid-derived suppressor cells and antitumor T cells: a complex relationship. Immunol. Invest. 41: 595-613.
11. Dietlin, T. A., F. M. Hofman, B. T. Lund, W. Gilmore, S. A. Stohlman, and R. C. van der Veen. 2007. Mycobacteria-induced Gr-1+ subsets from distinct myeloid lineages have opposite effects on T cell expansion. J. Leukoc. Biol. 81: 1205-1212. (Pubitemid 46702039)
12. Martino, A., E. Badell, V. Abadie, V. Balloy, M. Chignard, M. Y. Mistou, B. Combadière, C. Combadière, and N. Winter. 2010. Mycobacterium bovis bacillus Calmette-Guérin vaccination mobilizes innate myeloid-derived suppressor cells restraining in vivo T cell priming via IL-1R-dependent nitric oxide production. J. Immunol. 184: 2038-2047.
13. Anthony, D. D., T. Umbleja, J. A. Aberg, M. Kang, K. Medvik, M. M. Lederman, M. G. Peters, M. J. Koziel, and E. T. Overton. 2011. Lower peripheral blood CD14+ monocyte frequency and higher CD34+ progenitor cell frequency are associated with HBV vaccine induced response in HIV infected individuals. Vaccine 29: 3558-3563.
14. Goñi, O., P. Alcaide, and M. Fresno. 2002. Immunosuppression during acute Trypanosoma cruzi infection: involvement of Ly6G (Gr1+)CD11b+ immature myeloid suppressor cells. Int. Immunol. 14: 1125-1134.
15. Iwata, Y., K. Furuichi, K. Kitagawa, A. Hara, T. Okumura, S. Kokubo, K. Shimizu, N. Sakai, A. Sagara, Y. Kurokawa, et al. 2010. Involvement of CD11b+ GR-1low cells in autoimmune disorder in MRL-Faslpr mouse. Clin. Exp. Nephrol. 14: 411-417.
16. Delano, M. J., P. O. Scumpia, J. S. Weinstein, D. Coco, S. Nagaraj, K. M. Kelly-Scumpia, K. A. O'Malley, J. L. Wynn, S. Antonenko, S. Z. Al-Quran, et al. 2007. MyD88-dependent expansion of an immature GR-1+CD11b+ population induces T cell suppression and Th2 polarization in sepsis. J. Exp. Med. 204: 1463-1474. (Pubitemid 46919883)
17. Koike, Y., T. Kanai, K. Saeki, Y. Nakamura, M. Nakano, Y. Mikami, Y. Yamagishi, N. Nakamoto, H. Ebinuma, and T. Hibi. 2012. MyD88-dependent interleukin-10 production from regulatory CD11b+Gr-1high cells suppresses development of acute cerulein pancreatitis in mice. Immunol. Lett. 148: 172-177.
18. Haile, L. A., R. von Wasielewski, J. Gamrekelashvili, C. Kruger, O. Bachmann, A. M. Westendorf, J. Buer, R. Liblau, M. P. Manns, F. Korangy, and T. F. Greten. 2008. Myeloid-derived suppressor cells in inflammatory bowel disease: a new immunoregulatory pathway. Gastroenterology 135: 871-881.e5.
19. Singh, U. P., N. P. Singh, B. Singh, L. J. Hofseth, D. D. Taub, R. L. Price, M. Nagarkatti, and P. S. Nagarkatti. 2012. Role of resveratrol-induced CD11b+ Gr-1+ myeloid derived suppressor cells (MDSCs) in the reduction of CXCR3+ T cells and amelioration of chronic colitis in IL-10-/- mice. Brain Behav. Immun. 26: 72-82.
20. Bowen, J. L., and J. K. Olson. 2009. Innate immune CD11b+Gr-1+ cells, suppressor cells, affect the immune response during Theiler's virus-induced demyelinating disease. J. Immunol. 183: 6971-6980.
21. Ioannou, M., T. Alissafi, L. Boon, D. Boumpas, and P. Verginis. 2013. In vivo ablation of plasmacytoid dendritic cells inhibits autoimmunity through expansion of myeloid-derived suppressor cells. J. Immunol. 190: 2631-2640.
22. Xia, S., H. Sha, L. Yang, Y. Ji, S. Ostrand-Rosenberg, and L. Qi. 2011. Gr-1+ CD11b+ myeloid-derived suppressor cells suppress inflammation and promote insulin sensitivity in obesity. J. Biol. Chem. 286: 23591-23599.
23. Qu, P., C. Yan, J. S. Blum, R. Kapur, and H. Du. 2011. Myeloid-specific expression of human lysosomal acid lipase corrects malformation and malfunction of myeloid-derived suppressor cells in lal-/- mice. J. Immunol. 187: 3854-3866.
24. Cheng, L., J. Wang, X. Li, Q. Xing, P. Du, L. Su, and S. Wang. 2011. Interleukin-6 induces Gr-1+CD11b+ myeloid cells to suppress CD8+ T cell-mediated liver injury in mice. PLoS ONE 6: e17631.
25. Turnquist, H. R., Z. Zhao, B. R. Rosborough, Q. Liu, A. Castellaneta, K. Isse, Z. Wang, M. Lang, D. B. Stolz, X. X. Zheng, et al. 2011. IL-33 expands suppressive CD11b+ Gr-1int and regulatory T cells, including ST2L+ Foxp3+ cells, and mediates regulatory T cell-dependent promotion of cardiac allograft survival. J. Immunol. 187: 4598-4610.
26. Adeegbe, D., P. Serafini, V. Bronte, A. Zoso, C. Ricordi, and L. Inverardi. 2011. In vivo induction of myeloid suppressor cells and CD4+Foxp3+ T regulatory cells prolongs skin allograft survival in mice. Cell Transplant. 20: 941-954.
27. Billiau, A. D., S. Fevery, O. Rutgeerts, W. Landuyt, and M. Waer. 2003. Transient expansion of Mac1+Ly6-G+Ly6-C+ early myeloid cells with suppressor activity in spleens of murine radiation marrow chimeras: possible implications for the graft-versus-host and graft-versus-leukemia reactivity of donor lymphocyte infusions. Blood 102: 740-748. (Pubitemid 36842001)
28. Highfill, S. L., P. C. Rodriguez, Q. Zhou, C. A. Goetz, B. H. Koehn, R. Veenstra, P. A. Taylor, A. Panoskaltsis-Mortari, J. S. Serody, D. H. Munn, et al. 2010. Bone marrow myeloid-derived suppressor cells (MDSCs) inhibit graft-versus-host disease (GVHD) via an arginase-1-dependent mechanism that is up-regulated by interleukin-13. Blood 116: 5738-5747.
29. Joo, Y. D., S. M. Lee, S. W. Lee, W. S. Lee, S. M. Lee, J. K. Park, I. W. Choi, S. G. Park, I. Choi, and S. K. Seo. 2009. Granulocyte colony-stimulating factor-induced immature myeloid cells inhibit acute graft-versus-host disease lethality through an indoleamine dioxygenase-independent mechanism. Immunology 128 (Suppl.): e632-e640.
30. Zhou, Z., D. L. French, G. Ma, S. Eisenstein, Y. Chen, C. M. Divino, G. Keller, S. H. Chen, and P. Y. Pan. 2010. Development and function of myeloid-derived suppressor cells generated from mouse embryonic and hematopoietic stem cells. Stem Cells 28: 620-632.
31. Wang, D., Y. Yu, K. Haarberg, J. Fu, K. Kaosaard, S. Nagaraj, C. Anasetti, D. Gabrilovich, and X. Z. Yu. 2013. Dynamic change and impact of myeloid-derived suppressor cells in allogeneic bone marrow transplantation in mice. Biol. Blood Marrow Transplant. 19: 692-702.
32. Cai, W., A. Qin, P. Guo, D. Yan, F. Hu, Q. Yang, M. Xu, Y. Fu, J. Zhou, and X. Tang. 2013. Clinical significance and functional studies of myeloid-derived suppressor cells in chronic hepatitis C patients. J. Clin. Immunol. 33: 798-808.
33. Gama, L., E. N. Shirk, J. N. Russell, K. I. Carvalho, M. Li, S. E. Queen, J. Kalil, M. C. Zink, J. E. Clements, and E. G. Kallas. 2012. Expansion of a subset of CD14highCD16negCCR2low/neg monocytes functionally similar to myeloid-derived suppressor cells during SIV and HIV infection. J. Leukoc. Biol. 91: 803-816.
34. Qin, A., W. Cai, T. Pan, K. Wu, Q. Yang, N. Wang, Y. Liu, D. Yan, F. Hu, P. Guo, et al. 2013. Expansion of monocytic myeloid-derived suppressor cells dampens T cell function in HIV-1-seropositive individuals. J. Virol. 87: 1477-1490.
35. Norris, B. A., L. S. Uebelhoer, H. I. Nakaya, A. A. Price, A. Grakoui, and B. Pulendran. 2013. Chronic but not acute virus infection induces sustained expansion of myeloid suppressor cell numbers that inhibit viral-specific T cell immunity. Immunity 38: 309-321.
36. Terabe, M., S. Matsui, J. M. Park, M. Mamura, N. Noben-Trauth, D. D. Donaldson, W. Chen, S. M. Wahl, S. Ledbetter, B. Pratt, et al. 2003. Transforming growth factor-β production and myeloid cells are an effector mechanism through which CD1d-restricted T cells block cytotoxic T lymphocyte-mediated tumor immunosurveillance: abrogation prevents tumor recurrence. J. Exp. Med. 198: 1741-1752. (Pubitemid 37494166)
37. DeNardo, D. G., J. B. Barreto, P. Andreu, L. Vasquez, D. Tawfik, N. Kolhatkar, and L. M. Coussens. 2009. CD4+ T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages. Cancer Cell 16: 91-102.
38. Cripps, J. G., J. Wang, A. Maria, I. Blumenthal, and J. D. Gorham. 2010. Type 1 T helper cells induce the accumulation of myeloid-derived suppressor cells in the inflamed Tgfb1 knockout mouse liver. Hepatology 52: 1350-1359.
39. Arora, M., S. L. Poe, A. Ray, and P. Ray. 2011. LPS-induced CD11b+Gr1intF4/80+ regulatory myeloid cells suppress allergen-induced airway inflammation. Int. Immunopharmacol. 11: 827-832.
40. Jeisy-Scott, V., W. G. Davis, J. R. Patel, J. B. Bowzard, W. J. Shieh, S. R. Zaki, J. M. Katz, and S. Sambhara. 2011. Increased MDSC accumulation and Th2 biased response to influenza A virus infection in the absence of TLR7 in mice. PLoS ONE 6: e25242.
41. Munera, V., P. J. Popovic, J. Bryk, J. Pribis, D. Caba, B. M. Matta, M. Zenati, and J. B. Ochoa. 2010. Stat 6-dependent induction of myeloid derived suppressor cells after physical injury regulates nitric oxide response to endotoxin. Ann. Surg. 251: 120-126.
42. Huang, B., P. Y. Pan, Q. Li, A. I. Sato, D. E. Levy, J. Bromberg, C. M. Divino, and S. H. Chen. 2006. Gr-1+CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host. Cancer Res. 66: 1123-1131. (Pubitemid 43165981)
43. Pan, P. Y., G. Ma, K. J. Weber, J. Ozao-Choy, G. Wang, B. Yin, C. M. Divino, and S. H. Chen. 2010. Immune stimulatory receptor CD40 is required for T-cell suppression and T regulatory cell activation mediated by myeloid-derived suppressor cells in cancer. Cancer Res. 70: 99-108.
44. Zhang, Y., Q. Liu, M. Zhang, Y. Yu, X. Liu, and X. Cao. 2009. Fas signal promotes lung cancer growth by recruiting myeloid-derived suppressor cells via cancer cell-derived PGE2. J. Immunol. 182: 3801-3808.
45. Serafini, P., S. Mgebroff, K. Noonan, and I. Borrello. 2008. Myeloid-derived suppressor cells promote cross-tolerance in B-cell lymphoma by expanding regulatory T cells. Cancer Res. 68: 5439-5449.
46. Schlecker, E., A. Stojanovic, C. Eisen, C. Quack, C. S. Falk, V. Umansky, and A. Cerwenka. 2012. Tumor-infiltrating monocytic myeloid-derived suppressor cells mediate CCR5-dependent recruitment of regulatory T cells favoring tumor growth. J. Immunol. 189: 5602-5611.
47. Yang, Z., B. Zhang, D. Li, M. Lv, C. Huang, G. X. Shen, and B. Huang. 2010. Mast cells mobilize myeloid-derived suppressor cells and Treg cells in tumor microenvironment via IL-17 pathway in murine hepatocarcinoma model. PLoS ONE 5: e8922.
48. Fujimura, T., S. Ring, V. Umansky, K. Mahnke, and A. H. Enk. 2012. Regulatory T cells stimulate B7-H1 expression in myeloid-derived suppressor cells in ret melanomas. J. Invest. Dermatol. 132: 1239-1246.
49. Yang, R., Z. Cai, Y. Zhang, W. H. Yutzy, IV, K. F. Roby, and R. B. Roden. 2006. CD80 in immune suppression by mouse ovarian carcinoma-associated Gr-1+ CD11b+ myeloid cells. Cancer Res. 66: 6807-6815. (Pubitemid 44085641)
50. Hoechst, B., L. A. Ormandy, M. Ballmaier, F. Lehner, C. Krüger, M. P. Manns, T. F. Greten, and F. Korangy. 2008. A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4+CD25+Foxp3+ T cells. Gastroenterology 135: 234-243. (Pubitemid 351899008)
51. Deshane, J., J. W. Zmijewski, R. Luther, A. Gaggar, R. Deshane, J. F. Lai, X. Xu, M. Spell, K. Estell, C. T. Weaver, et al. 2011. Free radical-producing myeloid-derived regulatory cells: potent activators and suppressors of lung inflammation and airway hyperresponsiveness. Mucosal Immunol. 4: 503-518.
52. Yin, B., G. Ma, C. Y. Yen, Z. Zhou, G. X. Wang, C. M. Divino, S. Casares, S. H. Chen, W. C. Yang, and P. Y. Pan. 2010. Myeloid-derived suppressor cells prevent type 1 diabetes in murine models. J. Immunol. 185: 5828-5834.
53. Chou, H. S., C. C. Hsieh, R. Charles, L. Wang, T. Wagner, J. J. Fung, S. Qian, and L. L. Lu. 2012. Myeloid-derived suppressor cells protect islet transplants by B7-H1 mediated enhancement of T regulatory cells. Transplantation 93: 272-282.
54. Numasaki, M., J. Fukushi, M. Ono, S. K. Narula, P. J. Zavodny, T. Kudo, P. D. Robbins, H. Tahara, and M. T. Lotze. 2003. Interleukin-17 promotes angiogenesis and tumor growth. Blood 101: 2620-2627. (Pubitemid 36857622)
55. Zhang, J. P., J. Yan, J. Xu, X. H. Pang, M. S. Chen, L. Li, C. Wu, S. P. Li, and L. Zheng. 2009. Increased intratumoral IL-17-producing cells correlate with poor survival in hepatocellular carcinoma patients. J. Hepatol. 50: 980-989.
56. Muranski, P., A. Boni, P. A. Antony, L. Cassard, K. R. Irvine, A. Kaiser, C. M. Paulos, D. C. Palmer, C. E. Touloukian, K. Ptak, et al. 2008. Tumor-specific Th17-polarized cells eradicate large established melanoma. Blood 112: 362-373.
57. Chatterjee, S., S. Das, P. Chakraborty, A. Manna, M. Chatterjee, and S. K. Choudhuri. 2013. Myeloid derived suppressor cells (MDSCs) can induce the generation of Th17 response from naive CD4+ T cells. Immunobiology 218: 718-724.
58. Novitskiy, S. V., M. W. Pickup, A. E. Gorska, P. Owens, A. Chytil, M. Aakre, H. Wu, Y. Shyr, and H. L. Moses. 2011. TGF-β receptor II loss promotes mammary carcinoma progression by Th17 dependent mechanisms. Cancer Discov. 1: 430-441.
59. He, D., H. Li, N. Yusuf, C. A. Elmets, J. Li, J. D. Mountz, and H. Xu. 2010. IL-17 promotes tumor development through the induction of tumor promoting microenvironments at tumor sites and myeloid-derived suppressor cells. J. Immunol. 184: 2281-2288.
60. Agaugué, S., E. D. Carosella, and N. Rouas-Freiss. 2011. Role of HLA-G in tumor escape through expansion of myeloid-derived suppressor cells and cytokinic balance in favor of Th2 versus Th1/Th17. Blood 117: 7021-7031.
61. Yi, H., C. Guo, X. Yu, D. Zuo, and X. Y. Wang. 2012. Mouse CD11b+Gr-1+ myeloid cells can promote Th17 cell differentiation and experimental autoimmune encephalomyelitis. J. Immunol. 189: 4295-4304.
62. Rieber, N., A. Brand, A. Hector, U. Graepler-Mainka, M. Ost, I. Schäfer, I. Wecker, D. Neri, A. Wirth, L. Mays, et al. 2013. Flagellin induces myeloid-derived suppressor cells: implications for Pseudomonas aeruginosa infection in cystic fibrosis lung disease. J. Immunol. 190: 1276-1284.
63. Jiao, Z., S. Hua, W. Wang, H. Wang, J. Gao, and X. Wang. 2013. Increased circulating myeloid-derived suppressor cells correlated negatively with Th17 cells in patients with rheumatoid arthritis. Scand. J. Rheumatol. 42: 85-90.
64. Gabrilovich, D. I., M. P. Velders, E. M. Sotomayor, and W. M. Kast. 2001. Mechanism of immune dysfunction in cancer mediated by immature Gr-1+ myeloid cells. J. Immunol. 166: 5398-5406. (Pubitemid 32374159)
65. Sinha, P., V. K. Clements, and S. Ostrand-Rosenberg. 2005. Interleukin-13-regulated M2 macrophages in combination with myeloid suppressor cells block immune surveillance against metastasis. Cancer Res. 65: 11743-11751. (Pubitemid 41821736)
66. Nagaraj, S., K. Gupta, V. Pisarev, L. Kinarsky, S. Sherman, L. Kang, D. L. Herber, J. Schneck, and D. I. Gabrilovich. 2007. Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer. Nat. Med. 13: 828-835. (Pubitemid 47038194)
67. Kusmartsev, S. A., Y. Li, and S.-H. Chen. 2000. Gr-1+ myeloid cells derived from tumor-bearing mice inhibit primary T cell activation induced through CD3/CD28 costimulation. J. Immunol. 165: 779-785. (Pubitemid 30484744)
68. Watanabe, S., K. Deguchi, R. Zheng, H. Tamai, L. X. Wang, P. A. Cohen, and S. Shu. 2008. Tumor-induced CD11b+Gr-1+ myeloid cells suppress T cell sensitization in tumor-draining lymph nodes. J. Immunol. 181: 3291-3300.
69. Connolly, M. K., J. Mallen-St Clair, A. S. Bedrosian, A. Malhotra, V. Vera, J. Ibrahim, J. Henning, H. L. Pachter, D. Bar-Sagi, A. B. Frey, and G. Miller. 2010. Distinct populations of metastases-enabling myeloid cells expand in the liver of mice harboring invasive and preinvasive intra-abdominal tumor. J. Leukoc. Biol. 87: 713-725.
70. Bronte, V., T. Kasic, G. Gri, K. Gallana, G. Borsellino, I. Marigo, L. Battistini, M. Iafrate, T. Prayer-Galetti, F. Pagano, and A. Viola. 2005. Boosting antitumor responses of T lymphocytes infiltrating human prostate cancers. J. Exp. Med. 201: 1257-1268. (Pubitemid 40629069)
71. Youn, J. I., and D. I. Gabrilovich. 2010. The biology of myeloid-derived suppressor cells: the blessing and the curse of morphological and functional heterogeneity. Eur. J. Immunol. 40: 2969-2975.
72. Nausch, N., I. E. Galani, E. Schlecker, and A. Cerwenka. 2008. Mononuclear myeloid-derived "suppressor" cells express RAE-1 and activate natural killer cells. Blood 112: 4080-4089.
73. Cuervo, H., N. A. Guerrero, S. Carbajosa, A. Beschin, P. De Baetselier, N. Gironès, and M. Fresno. 2011. Myeloid-derived suppressor cells infiltrate the heart in acute Trypanosoma cruzi infection. J. Immunol. 187: 2656-2665.
74. Lesokhin, A. M., T. M. Hohl, S. Kitano, C. Cortez, D. Hirschhorn-Cymerman, F. Avogadri, G. A. Rizzuto, J. J. Lazarus, E. G. Pamer, A. N. Houghton, et al. 2012. Monocytic CCR2+ myeloid-derived suppressor cells promote immune escape by limiting activated CD8 T-cell infiltration into the tumor microenvironment. Cancer Res. 72: 876-886.
75. Lechner, M. G., D. J. Liebertz, and A. L. Epstein. 2010. Characterization of cytokine-induced myeloid-derived suppressor cells from normal human peripheral blood mononuclear cells. J. Immunol. 185: 2273-2284.
76. Choi, J., B. Suh, Y. O. Ahn, T. M. Kim, J. O. Lee, S. H. Lee, and D. S. Heo. 2012. CD15+/CD16low human granulocytes from terminal cancer patients: granulocytic myeloid-derived suppressor cells that have suppressive function. Tumour Biol. 33: 121-129.
77. Ko, J. S., A. H. Zea, B. I. Rini, J. L. Ireland, P. Elson, P. Cohen, A. Golshayan, P. A. Rayman, L. Wood, J. Garcia, et al. 2009. Sunitinib mediates reversal of myeloid-derived suppressor cell accumulation in renal cell carcinoma patients. Clin. Cancer Res. 15: 2148-2157.
78. Raychaudhuri, B., P. Rayman, J. Ireland, J. Ko, B. Rini, E. C. Borden, J. Garcia, M. A. Vogelbaum, and J. Finke. 2011. Myeloid-derived suppressor cell accumulation and function in patients with newly diagnosed glioblastoma. Neuro-oncol. 13:591-599.
79. Ioannou, M., T. Alissafi, I. Lazaridis, G. Deraos, J. Matsoukas, A. Gravanis, V. Mastorodemos, A. Plaitakis, A. Sharpe, D. Boumpas, and P. Verginis. 2012. Crucial role of granulocytic myeloid-derived suppressor cells in the regulation of central nervous system autoimmune disease. J. Immunol. 188: 1136-1146.
80. Nagaraj, S., A. Nelson, J. I. Youn, P. Cheng, D. Quiceno, and D. I. Gabrilovich. 2012. Antigen-specific CD4+ T cells regulate function of myeloid-derived suppressor cells in cancer via retrograde MHC class II signaling. Cancer Res. 72: 928-938.
81. Poschke, I., D. Mougiakakos, J. Hansson, G. V. Masucci, and R. Kiessling. 2010. Immature immunosuppressive CD14+HLA-DR-/low cells in melanoma patients are Stat3hi and overexpress CD80, CD83, and DC-sign. Cancer Res. 70: 4335-4345.
82. Filipazzi, P., R. Valenti, V. Huber, L. Pilla, P. Canese, M. Iero, C. Castelli, L. Mariani, G. Parmiani, and L. Rivoltini. 2007. Identification of a new subset of myeloid suppressor cells in peripheral blood of melanoma patients with modulation by a granulocyte-macrophage colony-stimulation factor-based antitumor vaccine. J. Clin. Oncol. 25: 2546-2553. (Pubitemid 47041228)
83. Solito, S., E. Falisi, C. M. Diaz-Montero, A. Doni, L. Pinton, A. Rosato, S. Francescato, G. Basso, P. Zanovello, G. Onicescu, et al. 2011. A human promyelocytic-like population is responsible for the immune suppression mediated by myeloid-derived suppressor cells. Blood 118: 2254-2265.
84. Zea, A. H., P. C. Rodriguez, M. B. Atkins, C. Hernandez, S. Signoretti, J. Zabaleta, D. McDermott, D. Quiceno, A. Youmans, A. O'Neill, et al. 2005. Arginase-producing myeloid suppressor cells in renal cell carcinoma patients: a mechanism of tumor evasion. Cancer Res. 65: 3044-3048. (Pubitemid 40524582)
85. Xiang, X., A. Poliakov, C. Liu, Y. Liu, Z. B. Deng, J. Wang, Z. Cheng, S. V. Shah, G. J. Wang, L. Zhang, et al. 2009. Induction of myeloid-derived suppressor cells by tumor exosomes. Int. J. Cancer 124: 2621-2633.
86. Rodriguez, P. C., C. P. Hernandez, D. Quiceno, S. M. Dubinett, J. Zabaleta, J. B. Ochoa, J. Gilbert, and A. C. Ochoa. 2005. Arginase I in myeloid suppressor cells is induced by COX-2 in lung carcinoma. J. Exp. Med. 202: 931-939. (Pubitemid 41396893)
87. Donkor, M. K., E. Lahue, T. A. Hoke, L. R. Shafer, U. Coskun, J. C. Solheim, D. Gulen, J. Bishay, and J. E. Talmadge. 2009. Mammary tumor heterogeneity in the expansion of myeloid-derived suppressor cells. Int. Immunopharmacol. 9: 937-948.